Cargando…
Head and neck cancer: metronomic chemotherapy
In the era of personalized medicine, head and neck squamous cell carcinoma (HNSCC) represents a critical oncologic topic. Conventional chemotherapy regimens consist of drugs administration in cycles near or at the maximum tolerated dose (MDT), followed by a long drug-free period to permit the patien...
Autores principales: | De Felice, Francesca, Musio, Daniela, Tombolini, Vincenzo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4603691/ https://www.ncbi.nlm.nih.gov/pubmed/26459302 http://dx.doi.org/10.1186/s12885-015-1705-z |
Ejemplares similares
-
Immune Check-Point Inhibitors and Standard Chemoradiotherapy in Definitive Head and Neck Cancer Treatment
por: De Felice, Francesca, et al.
Publicado: (2021) -
Radiation therapy and serum salivary amylase in head and neck cancer
por: De Felice, Francesca, et al.
Publicado: (2017) -
Weekly hypofractionated radiation therapy in elderly non-resectable cutaneous squamous cell carcinoma of the head and neck region
por: De Felice, Francesca, et al.
Publicado: (2020) -
Management of persistent anal canal carcinoma after combined-modality therapy: a clinical review
por: Musio, Daniela, et al.
Publicado: (2014) -
The role of radiation therapy in bone metastases management
por: Felice, Francesca De, et al.
Publicado: (2017)